# Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

> **NCT00368862** · PHASE4 · COMPLETED · sponsor: **Finnish Institute for Health and Welfare** · enrollment: 80 (—)

## Conditions studied

- Alcoholism
- Depression

## Interventions

- **DRUG:** Ebixa (memantine hydrochloride)
- **DRUG:** Cipralex (escitalopram)

## Key facts

- **NCT ID:** NCT00368862
- **Lead sponsor:** Finnish Institute for Health and Welfare
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 80 (—)
- **Last updated:** 2006-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00368862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00368862, "Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00368862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*